BMS and Sanofi-Aventis issued civil investigative demands

Share this article:
The FTC has issued civil investigative demands, which act like subpoenas, to Bristol-Myers Squibb and Sanofi-Aventis for documents relating to efforts to delay Apotex and other competition for Plavix (clopidogrel bisulfate).

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions